<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xsi:schemaLocation="http://www.sec.gov/edgar/thirteenffiler eis_13F_Filer.xsd" xmlns:ns1="http://www.sec.gov/edgar/common" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sec.gov/edgar/thirteenffiler">
  <schemaVersion>X0202</schemaVersion>
  <headerData>
    <submissionType>13F-NT</submissionType>
    <filerInfo>
      <liveTestFlag>LIVE</liveTestFlag>
      <flags/>
      <filer>
        <credentials>
          <cik>0001950105</cik>
          <ccc>XXXXXXXX</ccc>
        </credentials>
      </filer>
      <periodOfReport>06-30-2025</periodOfReport>
    </filerInfo>
  </headerData>
  <formData>
    <coverPage>
      <reportCalendarOrQuarter>06-30-2025</reportCalendarOrQuarter>
      <isAmendment>false</isAmendment>
      <filingManager>
        <name>Bain Capital Life Sciences Opportunities III, LP</name>
        <address>
          <ns1:street1>200 Clarendon Street </ns1:street1>
          <ns1:city>Boston</ns1:city>
          <ns1:stateOrCountry>MA</ns1:stateOrCountry>
          <ns1:zipCode>02116</ns1:zipCode>
        </address>
      </filingManager>
      <reportType>13F NOTICE</reportType>
      <form13FFileNumber>028-22966</form13FFileNumber>
      <otherManagersInfo>
        <otherManager>
          <form13FFileNumber>28-18477</form13FFileNumber>
          <name>Bain Capital Life Sciences Investors, LLC</name>
        </otherManager>
        <otherManager>
          <form13FFileNumber>28-22975</form13FFileNumber>
          <name>Bain Capital Life Sciences III General Partner, LLC</name>
        </otherManager>
        <otherManager>
          <form13FFileNumber>28-22979</form13FFileNumber>
          <name>Bain Capital Life Sciences Fund III, L.P.</name>
        </otherManager>
        <otherManager>
          <form13FFileNumber>28-22968</form13FFileNumber>
          <name>Bain Capital Life Sciences Opportunities III GP, LLC</name>
        </otherManager>
      </otherManagersInfo>
      <provideInfoForInstruction5>Y</provideInfoForInstruction5>
      <additionalInformation>The report on Form 13F for the period ended June 30, 2025 for Bain Capital Life Sciences Opportunities III, LP (the "Fund") is being filed by Bain Capital Life Sciences Investors, LLC, which is the manager of Bain Capital Life Sciences III General Partner, LLC, which is the general partner of Bain Capital Life Sciences Fund III, L.P., which is the sole member of Bain Capital Life Sciences Opportunities III GP, LLC, which is the general partner of the Fund.</additionalInformation>
    </coverPage>
    <signatureBlock>
      <name>Adam Koppel</name>
      <title>Partner of Bain Capital Life Sciences Investors, LLC</title>
      <phone>617-516-2000</phone>
      <signature>/s/ Adam Koppel</signature>
      <city>Boston </city>
      <stateOrCountry>MA</stateOrCountry>
      <signatureDate>08-14-2025</signatureDate>
    </signatureBlock>
  </formData>
</edgarSubmission>
